Park Jae Yong, Kim Sang Gyun, Kim Jung, Han Seung Jun, Oh Sooyeon, Choi Ji Min, Lim Joo Hyun, Chung Hyunsoo, Jung Hyun Chae
Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
PLoS One. 2017 Sep 26;12(9):e0185501. doi: 10.1371/journal.pone.0185501. eCollection 2017.
Metachronous gastric tumor (MGT) is one of major concerns after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). Optimal follow-up strategy has not been yet well-established. The aim of this study was to identify the different clinical features of the patients according to the time interval to development of MGT.
Among 1,780 consecutive patients with EGC who underwent ESD between 2005 and 2014, 115 patients with MGT were retrospectively reviewed. MGT was defined as secondary gastric cancer or dysplasia detected > 1 year after initial ESD. Clinicopathological factors associated with early development of MGT were evaluated.
The median interval to development of MGT was 37 months. In univariate analysis, the median interval to MGT was shorter if EGC lesion was non-elevated type (39.4 vs 57.0 months, p = 0.011), or synchronous primary lesion was absent (39.8 vs 51.4 months, p = 0.050). In multivariate Cox's proportional hazards analysis, the hazard ratios for early occurrence of MGT were 1.966 (95% CI: 1.141-3.386, p = 0.015) and 1.911 (95% CI: 1.163-3.141, p = 0.011), respectively. There was no significant difference in overall survival after diagnosis of MGT between the early occurrence group and the late occurrence group.
Non-elevated gross type and absence of synchronous gastric tumor were independent risk factors for early development of MGT. Meticulous endoscopic inspection is especially important for the detection of MGT during the early follow-up period in patients with these initial tumor characteristics.
异时性胃肿瘤(MGT)是早期胃癌(EGC)内镜黏膜下剥离术(ESD)后主要关注的问题之一。最佳随访策略尚未完全确立。本研究的目的是根据MGT发生的时间间隔确定患者的不同临床特征。
回顾性分析2005年至2014年间连续接受ESD治疗的1780例EGC患者,其中115例发生MGT。MGT定义为初次ESD后1年以上检测到的继发性胃癌或发育异常。评估与MGT早期发生相关的临床病理因素。
MGT发生的中位间隔时间为37个月。单因素分析显示,如果EGC病变为非隆起型(39.4个月对57.0个月,p = 0.011)或无同步原发性病变(39.8个月对51.4个月,p = 0.050),则MGT发生的中位间隔时间较短。多因素Cox比例风险分析显示,MGT早期发生的风险比分别为1.966(95%CI:1.141 - 3.386,p = 0.015)和1.911(95%CI:1.163 - 3.141,p = 0.011)。MGT诊断后的总生存率在早期发生组和晚期发生组之间无显著差异。
非隆起型大体类型和无同步胃肿瘤是MGT早期发生的独立危险因素。对于具有这些初始肿瘤特征的患者,在早期随访期间进行细致的内镜检查对于MGT的检测尤为重要。